AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Epirubicin Hydrochloride

32 registrations across 3 African markets— 16 active

Markets with Epirubicin Hydrochloride

🇿🇦South Africa
27 registrations
13 active
🇬🇭Ghana
3 registrations
2 active
🇳🇬Nigeria
2 registrations
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
Puridox Injection_
Solution for infusion
🇳🇬NigeriaManola Pharmaceuticals LimitedactiveAug 2029
EPIRUBICIN HYDROCHLORIDE CONCENTRATE FOR SOLUTION FOR INFUSION🇬🇭Ghana—activeDec 2026
EPIRUBICIN HYDROCHLORIDE CONCENTRATE FOR SOLUTION FOR INFUSION🇬🇭Ghana—activeDec 2026
PHARMORUBICIN POWDER FOR INJECTION🇬🇭Ghana—expiredJun 2026
ASPEN EPIRUBICIN 50 mg🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
ASPEN EPIRUBICIN 20 mg/10 ml🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
ASPEN EPIRUBICIN 10 mg🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
ASPEN EPIRUBICIN 50 mg/25 ml🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
ASPEN EPIRUBICIN 10 mg/5 ml🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
ASPEN EPIRUBICIN 100 mg/50 ml🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
ASPEN EPIRUBICIN 200 mg/100 ml🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedSept 2025
EPIRUBICIN-HEXAL 50 mg/25 ML🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedAug 2025
EPIRUBICIN HCL-HEXAL 10 mg/5 ML🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedAug 2025
CIPLA-EPIRUBICIN 10🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
FARMORUBICIN CSV 10 mg/5 ml🇿🇦South AfricaPfizer Laboratories (Pty) LtdsuspendedMar 2024
FARMORUBICIN CSV 50 mg/25 ml🇿🇦South AfricaPfizer Laboratories (Pty) LtdsuspendedMar 2024
RUBILON 50 POWDER FOR INJECTION
50MG
🇳🇬NigeriaL''PACEMAKERS PHARM. 11expiredFeb 2022
EPIRUBICIN-HEXAL 200 mg/100 ML🇿🇦South AfricaHEXAL PHARMA (SA) (PTY) LTDsuspendedJan 2022
EPIRUBICIN-HEXAL 100 mg/50 ML🇿🇦South AfricaHEXAL PHARMA (SA) (PTY) LTDsuspendedJan 2022
EPIRUBICIN 50 mg/25 ml FRESENIUS🇿🇦South AfricaFresenius Kabi South Africa (Pty) LtdactiveNov 2020
EPIRUBICIN 200 mg/100 ml FRESENIUS🇿🇦South AfricaFresenius Kabi South Africa (Pty) LtdactiveNov 2020
EPIRUBICIN 10 mg/5 ml FRESENIUS🇿🇦South AfricaFresenius Kabi South Africa (Pty) LtdactiveNov 2020
HX-EPIRUBICIN 200 mg/100 ML🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
HX-EPIRUBICIN 100 mg/50 ML🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
HX-EPIRUBICIN 50 mg/25 ML🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
MERCK EPIRUBICIN 10 mg🇿🇦South AfricaViatris South Africa (Pty) LtdactiveJan 1900
HX-EPIRUBICIN 10 mg/5 ML🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
MERCK EPIRUBICIN 50 mg🇿🇦South AfricaViatris South Africa (Pty) LtdactiveJan 1900
EPICORD 10🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveJan 1900
FARMORUBICIN RD 10🇿🇦South AfricaPfizer Laboratories (Pty) LtdactiveJan 1900
FARMORUBICIN RD 50🇿🇦South AfricaPfizer Laboratories (Pty) LtdactiveJan 1900
EPICORD 50🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveJan 1900

Epirubicin Hydrochloride in Africa — Regulatory Overview

Epirubicin Hydrochloride is registered across 3 African markets with 32 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 32 registrations, 16 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.